Inci Dersu, MD, MPH

Dr. Dersu is an American Board certified ophthalmologist and fellowship trained glaucoma specialist. She was the director of glaucoma service and inaugural recipient of John Nutt Endowed Chair at the University of Arkansas before joining SUNY Downstate Health Sciences University in 2013. She specializes in medical and surgical treatment of all types of glaucoma in addition to performing cataract surgery. A recipient of American Glaucoma Society led Patient Care Improvement Project award, her goal is to provide high quality patient centered care by using the latest available technology. Dr. Dersu has been named one of the Best Doctors  by the Castle-Connolly Guide.

Dr. Dersu has passion to mentor and teach students and residents. She is the recipient of the Diversity in Medicine Mentorship Award in addition to Graduate Medical Education Teacher of the Year Award.

Education

• Undergraduate: Hacettepe University School of Medicine, Ankara, Turkey
• Medical School: Hacettepe University School of Medicine, Ankara, Turkey
• Residency: Ankara University School of Medicine; Cooper Hospital, UMDNJ, Camden, New Jersey
• Fellowship: Shiley Eye Center, University of California, San Diego; Moran Eye Center, University of Utah, Salt Lake City, Utah
• Advanced Degree: University of Arkansas, MPH

Research Interests

• Investigating the barriers in detection and successful treatment of glaucoma in the African American and Caribbean Population

• Improving medication adherence

• Patient’s perspective on outcome after laser and other surgical interventionMPH: College of Public Health, University of Arkansas, Little Rock, Arkansas

• Irak-Dersu I, Thostenson J, Anderson J, et al. Correlations of Afferent Pupillary Defect, Retinal Nerve Fiber Layer Thickness, and Visual Field in Asymmetric Optic Neuropathies. Clinic Experiment Ophthalmol 2011, 2(5):183
• Dersu I, Thostenson J, Durcan J, et al. Optic Disc and Visual Test Findings in Patients with Migraine. J Clinical Neuroscience. J Clin Neurosci. 2013 Jan;20(1):72-4
• Dersu II, Spencer HT, Grigorian P, et al. The Effect of Mydriatic solutions on Cognitive Function. Semin Ophthalmol. 2013 Aug 16.
• Dersu II, Ali TK, Spencer HJ, Covey SM, Evans MS, Harper RA. Psychomotor Vigilance and Visual Field Test Performance. Semin Ophthalmol. 2014 Feb 7.
• Pansegrau M, Mengerelli E, Irak Dersu I. Complication of an Ahmed Glaucoma Valve Implant., Digital Journal of Ophthalmology. 2015 Vol 21, Number 4.
• Cao F, Irak Dersu I. Elevated IOP After Laser Treatment. Glaucoma Today. November/December 2018.
• Gordon D, Parendo A, Irak Dersu I. Hypopigmentation Following Brimonidine Induced Contact Dermatitis.Digital Journal of Ophthalmology. July 9, 2019
• Gold FE, Yadollahikhales M, Dersu II. National Utilization of Glaucoma Laser and Surgical Management in Medicare Beneficiaries: Disparities and Accessibility. J Glaucoma.  2023; 32 (12) 1038-1043. 10.1097/IJG.0000000000002258. Online ahead of print. (Open access).
• Duong T, Van Tasse SH, Alzaga Fernandez AG, Amin A, Chadha N, Dagi Glass LR, Dersu I, Goyal A, Graubart EB, Elkin ZP, Kelly L, Kemp PS, Knoch DW, Regina M, Rosenbaum PS, Rosenberg JB, Sankar PS, Sun G. Medical Education and Path to Residency in Ophthalmology in the COVID-19 Era: A Perspective from Medical Student Educators. Ophthalmology. Vol 127,Issue 11, November 2020, Pages e95-98.
• Gordon D, Parendo A, Dersu I. Hypopigmentation Following Brimonidine induced Contact Dermatitis. Digital Journal of Ophthalmology 2019 Vol 25, Number 2.